InsidersTradesSigma
Explore the detailed record of transactions filed by Swirsky Douglas J, Director. Officer active across 1 companies, notably Cellectar Biosciences, Inc.. Aggregated, 2 disclosures have been published. Total volume traded: €44k. The latest transaction was disclosed on 14 September 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Douglas J. Swirsky is a Board Member at Cellectar Biosciences, Inc. He plays an important role in overseeing the company's activities and developing its growth strategy.